Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
|
|
Adverum Biotechnologies, Inc. (ADVM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/21/2022 |
4/A
| Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 33,333 shares
@ $0 |
|
| 05/20/2020 |
4/A
| Gasmi Mehdi (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 88,496 shares
@ $0
Paid exercise price by delivering 31,482 shares
@ $11.33, valued at
$356.7k
Paid exercise price by delivering 15,494 shares
@ $15.05, valued at
$233.2k
Sold 10,000 shares
@ $15.069, valued at
$150.7k
Exercised 10,000 options to buy
@ $4.8, valued at
$48k
|
|
| 05/08/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/14/2020 |
4/A
| Gasmi Mehdi (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Paid exercise price by delivering 15,494 shares
@ $10.24, valued at
$158.7k
|
|
| 02/10/2020 |
4/A
| Gasmi Mehdi (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 88,496 shares
@ $0 |
|
| 02/10/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/25/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|